Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2003
10/30/2003WO2002061050A3 Methods for determining ring number in carotenoids by lycopene epsilon-cyclases and uses thereof
10/30/2003WO2002059607A3 Isolation of epidermal stem cells by using the melanoma-associated chondroitin sulfate proteoglycan
10/30/2003WO2002059327A3 Sulfatases and methods of use thereof
10/30/2003WO2002059322A3 Compositions and methods relating to the daptomycin biosynthetic gene cluster
10/30/2003WO2002059283A3 Nucleic acid modification enzymes
10/30/2003WO2002057476A3 Methods and microorganisms for the production of 3-(2-hydroxy-3-methyl-butyrylamino)-propionic acid (hmbpa)
10/30/2003WO2002055704A3 Proteins, polynucleotides encoding them and methods of using the same
10/30/2003WO2002053779A3 Cell-free assay and in vivo method for plant genetic repair using chloroplast lysate
10/30/2003WO2002053703A3 Aav2 vectors and methods
10/30/2003WO2002050280A3 Equine ige allotype
10/30/2003WO2002050244A3 Antisense modulation of histone deacetylase 1 expression
10/30/2003WO2002044361A8 Eukaryotic expression libraries based on double lox recombination and methods of use
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002028175A9 Transgenic mouse for targeted recombination mediated by modified cre-er
10/30/2003WO2002027023A9 Genetic determinants for dermal inflammation and immunity
10/30/2003WO2002026826A3 Proteins and nucleic acids encoding same
10/30/2003WO2002026817A3 33521, a human guanine nucleotide exchange family member and uses thereof
10/30/2003WO2002022821A3 Antimicrobial peptides and methods of use
10/30/2003WO2002022819A3 Calcium binding proteins
10/30/2003WO2002020716A3 Antisense modulation of phosphorylase kinase alpha 2 expression
10/30/2003WO2002018583A9 Modified polypeptides stabilized in a desired conformation and methods for producing same
10/30/2003WO2002017711A9 Therapeutics and diagnostics based on a novel signal transduction system in platelets
10/30/2003WO2002014858A3 Method for producing and identifying appropriate effectors of target molecules using substance libraries
10/30/2003WO2002012555A3 Means for targeting nucleic acid repeat regions
10/30/2003WO2002010414A9 Expression of biologically active polypeptides in duckweed
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003WO2001090302A3 Compositions and methods for production of rna viruses and rna virus-based vector particles
10/30/2003WO2001085995A3 Identification of neural defects associated with the nucleosom al assembly protein 1l2 gene
10/30/2003WO2001074136A3 Telomerase inhibitor polynucleotides
10/30/2003US20030204875 Novel agrobacterium-mediated plant transformation method
10/30/2003US20030204874 Genetically engineered plants coding abscisic acid responsive element binding factor (ABF) for generating dought and environmental stress resistant plants
10/30/2003US20030204873 Generating genetically engineered herbicide resistant monocotyledons
10/30/2003US20030204872 Comprises nucleotide sequences coding phytochrome A (PHYA) for generation of plants with belated flowering and reduced stature
10/30/2003US20030204871 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and related fatty acids having a modification at the delta-9 position
10/30/2003US20030204870 Alteration of oil traits in plants
10/30/2003US20030204869 Method to control the ripening of papaya fruit and confer disease resistance to papaya plants
10/30/2003US20030204868 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
10/30/2003US20030204867 Nucleotide sequences coding transport protein for generating transgenic crop plants with adjusted nitrogen metabolism and which grow on acidic soils; increased biomass production
10/30/2003US20030204865 CaaX prenyl protease nucleic acids and polypeptides and methods of use thereof
10/30/2003US20030204864 Stable plastid transformation and expression vector for transferring target nucleotide sequences into plants for mass production of affordable vaccines and pharmaceutical agents
10/30/2003US20030204863 Nav2 channel gene-deficient non-human animals
10/30/2003US20030204862 Inbred embryonic stem-cell derived mice
10/30/2003US20030204861 Transgenic animal model for spliceosome-mediated RNA trans-splicing
10/30/2003US20030204860 Cloning non-human mammals through nuclear transfer/ transplantation
10/30/2003US20030204331 Automated sample preparation methods and devices
10/30/2003US20030204321 Efficient algorithm for PCR testing of blood samples
10/30/2003US20030204318 Determination of interference RNAs (iRNAs) and small temporal RNAs (stRNAs) and their interaction with connectrons in prokaryotic, archea and eukaryotic genomes
10/30/2003US20030204077 RNA isolation reagent and methods
10/30/2003US20030204076 Antisense modulation of vascular endothelial growth factor receptor-1 expression
10/30/2003US20030204073 Identifying an allosteric modulator/antagonist of g-protein coupled receptors for treatment of metabolic disorders
10/30/2003US20030204072 Comprises receptor protein tyrosine kinase (rPTK) for diagnosing and treating kidney or neurodegenerative diseases
10/30/2003US20030204071 109 human secreted proteins
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030204068 Nucleotide sequences coding campylobacter proteins for use in preventing bacterial, fungal and viral infection as well as treat gastrointestinal disorders and peptic ulcers; genetic vaccines
10/30/2003US20030204065 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders
10/30/2003US20030204060 Prepared by fermenting, incubating and eluting by washing with buffer, then chromatographing concentrated medium with lipophilic immobile phase comprising carrier coupled to 2-mercapto/hydroxyalkanoic acid
10/30/2003US20030204058 Dendritic enriched secreted lymphocyte activation molecule
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030203987 Pigment containing ink and production method thereof
10/30/2003US20030203871 Novel cationic cholesteryl derivatives containing cyclic polar groups
10/30/2003US20030203870 Method and reagent for the inhibition of NOGO and NOGO receptor genes
10/30/2003US20030203868 Inhibition of pathogen replication by RNA interference
10/30/2003US20030203865 Lipid-comprising drug delivery complexes and methods for their production
10/30/2003US20030203864 Treatment of cancer
10/30/2003US20030203863 Interleukins (IL-2); cytokines; bovine growth hormone; cytomegalovirus; gene therapy
10/30/2003US20030203862 An antisense compound 8 to 30 nucleobases targeted to 5' untranslated region, coding region, intron:exon junctin, intron region, exon region, translation termination codon region or 3' untranslated region of nucleic acid molecule
10/30/2003US20030203861 Nucleic acid vector containing a non-coding, immunostimulatory polynucleotide, comprised of six nucleotides arranged in the sequence 5'-purine-purine-unmethylated CpG-pyrimidine-pyrimidine-3'
10/30/2003US20030203847 Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules
10/30/2003US20030203842 Apolipoprotein A-l agonists and their use to treat dyslipidemic disorders
10/30/2003US20030203840 Nucleic acid containing at least one adenine base, a guanine base, a cytosine base, and at least thymin or uracil base and nucleic acid is atleast 12 bases in length, hybridizes to sense or antisense strand of second nucleic acid
10/30/2003US20030203497 Using bioassay to monitor combinatorial library synthesis and rank products in order of their ability to bind to a target molecule which is capable of unfolding when heated
10/30/2003US20030203489 Pseudotype retroviral vectors containing membrane proteins having hemagglutinin activity
10/30/2003US20030203488 Plasmid comprising components from herpesvirus, cytomegalovirus, adeno-associated virus, poxvirus and adenovirus which permits the transfer and expression of genes of interest in preferential cells
10/30/2003US20030203487 Using circular nucleic acid integration vector, restriction enzymes and transposase to transfer and insert preferential nucleotide sequences into target genome
10/30/2003US20030203486 Transfection method and uses related thereto
10/30/2003US20030203484 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/30/2003US20030203482 Stimulation of cellular regeneration and differentiation tn the inner ear
10/30/2003US20030203481 Miniaturized achromosomal, anucleotic, synthetic cells for use as diagnostics and drug disocovery tools in proteomics
10/30/2003US20030203480 Method of preparing a eukaryotic viral vector
10/30/2003US20030203472 Episome for transfer and expression of heterologous nucleotide sequences in gram positive bacteria; genetic vaccines
10/30/2003US20030203467 Novel variant EGIII-like cellulase compositions
10/30/2003US20030203466 Comprises hydrolase for treating textiles, degrading plant biomass and fracturing subterranean formations
10/30/2003US20030203464 Comprise Gtpase (RAC-GEF) polypeptide for treating diagnosis and treatment of cell proliferative disorders; antiproliferative agents
10/30/2003US20030203463 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
10/30/2003US20030203462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203460 Biocatalytic synthesis of quinic acid and conversion to hydroquinone
10/30/2003US20030203455 Heat-stable D-aminoacylase
10/30/2003US20030203453 Isolating expression vectors or circular DNA from lysed cells using ultrafiltration/microfiltration
10/30/2003US20030203452 Human chemokine beta-13
10/30/2003US20030203449 Novel 2,5-diketo-L-gluconic acid reductases and methods of use
10/30/2003US20030203447 Methods and materials for increasing expression of recombinant polypeptides
10/30/2003US20030203440 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203439 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203437 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203432 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203431 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203430 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203428 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203426 Comprises proteins for diagnosis, treatment and prevention of arthritis, muscular, cancer, nervous system, sex and urogenital disorders